Inflexion makes it three healthcare deals in a year with Proteros move

Proteros focuses on early-stage drug discovery and works with companies in Europe, the US and Japan.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this